NCT05580055

Enrolling By Invitation

Blood Testing at Entia

Entia Ltd Source

Compare

Other study identifiers

Sponsor study identifier

298186

Study Type

observational

Estimated enrollment

100

Locations

1 country

Sites

1

Timeline

Study Start

October 22, 2021

Actual (reported)

Primary Completion

October 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

October 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Brief Summary

The investigators are recruiting healthy volunteers to donate 1-5 (depending on study visits. and donors will be notified upon invitation) finger prick blood samples or venous samples to Entia for the further development and testing of our blood analyser. The venous samples are taken by a registered nurse hired via a third party company. The results of the blood tests are not informed to the participants unless they explicitly ask for it.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: enrolling by invitation
Estimated enrollment: 100 participants
Study completion date: October 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 22, 2021
Actual (reported)
First Submitted
October 11, 2022
Actual (reported)
First Posted
October 14, 2022
Actual (reported)
Primary Completion
October 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
October 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated: August 21, 2026
Status Verified: August 2026
Last Update Submitted: August 20, 2026

Conditions

Blood Cell Count Healthy

Outcome Measures

Primary Outcomes (1)

The difference in counts of the device tested blood vs the gold standard tested blood.
Venous blood drawn will be tested on a laboratory analyser, in which the results will be compared against the results of blood samples (whether capillary or venous) when tested on Entia's analyser.
Day 1

Study Arms (2)

Capillary Sample

This group donates finger prick blood samples to Entia for the purpose of development.

Diagnostic Test: Affinity

Venous Sample

This group donates venous blood samples to Enta, taken by a registered nurse.

Diagnostic Test: Affinity

Interventions

AffinityDiagnostic test

Blood Analyser

Capillary SampleVenous Sample

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Healthy volunteers, enrolled by invitation only

You may qualify if:

Aged ≥ 21 years Apparently healthy Able to provide written informed consent Registered with a general practitioner (GP)

You may not qualify if:

Sponsors & Collaborators

Entia Ltd
Industrylead

Study Sites (1)

Entia Ltd

London, London, WC1X 8LU, United Kingdom

MeSH Terms

Interventions

Antibody Affinity

Intervention Hierarchy (Ancestors)

Immune System PhenomenaAntigen-Antibody Reactions

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 11, 2022

First Posted

October 14, 2022

Study Start

October 22, 2021

Actual (reported)

Primary Completion

October 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

NCT05051566

A Multiple Dose Study of LY3502970 in Healthy Participants

Phase 1Completed

NCT05335447

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667

Phase 1Completed

NCT04907149

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

Phase 1Completed

NCT05077436

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Phase 1Completed

NCT04848402

A Device Study in Healthy Participants

Phase 1Completed

NCT05260346

Modulation of the Gut-brain Axis by Cranberries: Impact on University Students' Mental Wellbeing

Not ApplicableCompleted

Inadequate understanding of the English language (written and verbal) that would require a translator Been hospitalised within 90 days prior to their study visit Donated whole blood or plasma to a blood bank within the 90 days prior to the study visit Pregnant at the time of the study visit Breastfeeding at the time of the study visit History of vasovagal syncope following blood draw
History or current diagnosis of the following conditions:
Cancer Cardiovascular disease Chronic kidney disease or end-stage renal disease Bleeding disorder (including but not limited to Immune Thrombocytopenia (ITP), hemophilia, von Willebrand disease (VWD)) Blood clotting disorder (including but not limited to thrombophilia, antiphospholipid syndrome) G6PD deficiency Inflammatory bowel disease Myelodysplastic syndrome Ebola Tuberculosis HIV Hepatitis B or C Current diagnosis of Epstein-Barr Virus or Cytomegalovirus Current diagnosis of diabetes mellitus, unless controlled by diet alone OR participant has been taking the same dose of the same medication for 4 weeks or more and are feeling fit and well.
Undergone organ transplantation Anemia, unless the participant is feeling fit and well (no dizziness, fatigue, shortness of breath etc)

Contact the study team to confirm eligibility.

Study Completion

October 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated

August 21, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05580055
Data provider: ClinicalTrials.gov
Source updated: 2026-08-21
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:25:35 UTC

Locations

GB(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Capillary Sample

Venous Sample

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Design

Study Record Dates

Data Sharing

Source record

Locations